You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
賽升藥業(300485.SZ):綠竹生物將於5月8日在香港聯交所主板上市
格隆匯 05-07 17:39

格隆匯5月7日丨賽升藥業(300485.SZ)公佈,公司參股公司北京綠竹生物技術股份有限公司(“綠竹生物”)將於2023年5月8日在香港聯合交易所主板上市,證券簡稱:綠竹生物-B,H股的股份代號02480.HK,發行價格為每股H股32.80港元。

綠竹生物是一家致力於開發創新型人類疫苗和治療性生物製劑,以預防和控制傳染性疾病,並治療癌症和自身免疫性疾病的生物技術公司。綠竹生物專注於人類醫學領域,並憑藉對免疫學和蛋白質工程的理解,建立了技術平台,可開發效率優良、高純度及穩定性有所改善的重組疫苗及抗體在研產品。

截至公吿披露日,公司持有綠竹生物1375.15萬股,佔綠竹生物公開發行前總股本的7.16%,公司之關聯方北京亦莊生物醫藥併購投資中心(有限合夥)及北京亦莊二期生物醫藥產業投資基金(有限合夥)分別持有綠竹生物1964.5萬股及1832.4696萬股,分別佔綠竹生物公開發行前總股本的10.23%及9.54%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account